Phio Advances PH-762 With FDA-Backed Toxicology Study
King of Prussia, Pennsylvania | December 23, 2025 — Phio Pharmaceuticals Corp. announced a significant advancement in its drug...
nonclinical toxicology
Advertisement
Advertisement
